Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Sinolink: Agent industry has entered a new round of prosperity cycle with rigid demand for CPU

New Stock Preview | Robotechnik Intelligent Technology: Market Value of 100 Billion vs. Profits Plummeting by 171%, Can the "Silicon Light Leader" Withstand Hong Kong Stock Examination?

New Stock News | Longfeng Group passes the hearing at the Hong Kong Stock Exchange, offering over 700 SKUs of its brands such as pharmaceuticals and cosmetics for sale.
Sinolink: Agent industry has entered a new round of prosperity cycle with rigid demand for CPU

New Stock Preview | Robotechnik Intelligent Technology: Market Value of 100 Billion vs. Profits Plummeting by 171%, Can the "Silicon Light Leader" Withstand Hong Kong Stock Examination?

New Stock News | Longfeng Group passes the hearing at the Hong Kong Stock Exchange, offering over 700 SKUs of its brands such as pharmaceuticals and cosmetics for sale.






